Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Victorion - RIDES: Inclisiran in Acute Coronary Syndromes
NCT07102628Phase 3Recruiting
- Sponsor
- Novartis
- Start
- Oct 2025
- Primary completion
- Feb 2027
- Modality
- Antisense DNA, Conjugated siRNA, MicroRNA (miRNA)
- Countries
- 14
01
Overview
A Phase 3 trial of inclisiran in acute coronary syndrome (ACS), sponsored by Novartis. Started Oct 2025; status: recruiting.
02
Drugs
inclisiran
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT07102628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07102628.